Type 2 Diabetes is a chronic condition that affects the way the body processes blood sugar (glucose). There’s no cure for type 2 diabetes, but you may be able to manage the condition by eating well, exercising and maintaining a healthy weight. If diet and exercise aren’t enough to manage your blood sugar well, you also may need diabetes medications or insulin therapy.
At Northern California Research we are conducting a study for a new medication to manage type 2 diabetes.
The study will compare Gan & Lee Pharmaceuticals Insulin Glargine Injection to Lantus (Insulin Glargine Injection) in adult subjects with type 2 diabetes.
The study includes 13 visits to the clinic over a 52-week period. Subjects with a confirmed diagnosis of type 2 diabetes mellitus who meet one of the following:
- Insulin-naïve and on at least 2 approved oral antidiabetic medications, and the clinician has decided to add insulin therapy
- If already being treated with a basal insulin, subjects should have been treated with insulin for at least 6 months in addition to at least 1 approved oral diabetic medication.
- HbA1c values as follows:
- If insulin-naïve, HbA1c ≤ 11.0%
- If previously on a basal insulin regimen, HbA1c ≥7.0% and ≤ 11.0%
No cost for physical exams, diabetic supplies such as lancets and insulin needles, medication, ECG’s, close monitoring of sugars and lab testing.
Compensation for participation: $650
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03371108